Dis-Chem Pharmacies (JSE:DCP) Long-Term Capital Lease Obligation : R2,473 Mil (As of Aug. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Long-Term Capital Lease Obligation?

Dis-Chem Pharmacies's Long-Term Capital Lease Obligation for the quarter that ended in Aug. 2023 was R2,473 Mil.

Dis-Chem Pharmacies's quarterly Long-Term Capital Lease Obligation increased from Aug. 2022 (R2,392 Mil) to Feb. 2023 (R2,661 Mil) but then declined from Feb. 2023 (R2,661 Mil) to Aug. 2023 (R2,473 Mil).

Dis-Chem Pharmacies's annual Long-Term Capital Lease Obligation declined from Feb. 2021 (R2,823 Mil) to Feb. 2022 (R2,682 Mil) and declined from Feb. 2022 (R2,682 Mil) to Feb. 2023 (R2,661 Mil).

Dis-Chem Pharmacies Long-Term Capital Lease Obligation Historical Data

The historical data trend for Dis-Chem Pharmacies's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Long-Term Capital Lease Obligation Chart

Dis-Chem Pharmacies Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2,443.20

2,374.96

2,823.05

2,682.28

2,660.59

Dis-Chem Pharmacies Semi-Annual Data
	Feb14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial														2,749.48	2,682.28	2,392.40	2,660.59	2,473.05

Dis-Chem Pharmacies (JSE:DCP) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Dis-Chem Pharmacies Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.